PATENT CLAIM ANALYSIS

Application Number: 16117372
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "093710"]

Abstract:
Disclosed herein are methods for treating cancer comprising administering CAR-modified immune cells and at least one Retinoic Acid Receptor agonist.

Claim (Index 11):
The method of  claim 9 , wherein the RAR\u03b1 agonist is a compound having a structure of formula (II): wherein R 1  is H or C 1-6  alkyl.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16034123', '16034064', '15868469', '15620411', '15868459']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7202941884855427
- 35 USC 102 Novelty (BERT): 0.6542896183851302
- Combined Prediction Score: 0.7136937314755014
- Mean Citation Score: 381.753286
- Max Citation Score: 695.2320599999997
- Similarity Product: 567.3183011885546

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test